CelLBxHealth plc

CLBX · AIM · Health Care · mcap £9.3m · 0.9p

Beta Briefing, track record and bull & bear case are not ready for CelLBxHealth plc yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 31 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 15 Jul 26 ↗

Going-concern uncertainty

Revenue: £1.2m
Operating profit: −£12.2m
Net income: −£12.9m
Free cash flow: −£9.8m
Net cash: £2.9m
Market cap: £9.7m
EV / EBIT: –
FCF yield: −101.4%
Price / book: 2.4×

Latest half-year · H1 26 vs H1 25 results 15 Jul 26 ↗

Revenue: £597k
Operating profit: −£2.7m
Net income: −£2.7m
Cash from operations: −£4.0m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 15 Jul 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25	FY 24
Revenue	1.2	1.4	2.9
Gross profit	0.7	0.8	1.8
Operating profit	(12.2)	(19.2)	(15.1)
Depreciation (owned assets)	1.5	1.6	–
Depreciation (right-of-use)	1.6	1.8	–
Amortisation	2.4	2.3	–
Share-based payments	(1.2)	(0.8)	1.5
Finance costs	(0.2)	(0.3)	(0.3)
Profit before tax	(12.3)	(19.4)	(15.0)
Tax	(0.6)	(0.1)	0.8
Net income (owners)	(12.9)	(19.5)	(14.2)
EPS basic	(2.9p)	(5.5p)	(4.8p)
EPS diluted	(2.9p)	(5.5p)	(4.8p)

	H1 26	vs H1 25	H2 25	H1 25
Revenue	0.6	−25%	0.6	0.8
Gross profit	0.4	−22%	0.4	0.5
Operating profit	(2.7)	n/m	(9.6)	(9.7)
Depreciation (owned assets)	0.3	−29%	1.2	0.4
Depreciation (right-of-use)	0.3	−35%	1.3	0.4
Amortisation	0.1	n/m	2.3	0.0
Share-based payments	(0.0)	n/m	(1.2)	0.4
Finance costs	(0.1)	−55%	(0.1)	(0.2)
Profit before tax	(2.7)	n/m	(9.7)	(9.7)
Tax	(0.0)	n/m	(0.6)	0.5
Net income (owners)	(2.7)	n/m	(10.2)	(9.3)
EPS basic	(0.2p)	–	(2.6p)	(2.9p)
EPS diluted	(0.2p)	–	(2.6p)	(2.9p)

	LTM Jun 26	FY 25	FY 24
Cash from operations	(8.7)	(9.3)	(13.4)
Capex (PP&E)	(0.2)	(0.2)	(0.4)
Capex (intangibles)	0.0	(0.0)	(0.0)
Lease principal paid	(0.8)	(1.0)	(0.8)
Lease interest paid	(0.2)	(0.3)	(0.2)
Share buybacks	–	(0.0)	–
Shares issued	–	7.6	8.6

	H1 26	vs H1 25	H2 25	H1 25
Cash from operations	(4.0)	n/m	(4.7)	(4.6)
Capex (PP&E)	(0.0)	n/m	(0.1)	(0.1)
Capex (intangibles)	0.0	n/m	(0.0)	(0.0)
Lease principal paid	(0.3)	−51%	(0.5)	(0.6)
Lease interest paid	(0.1)	−49%	(0.2)	(0.1)
Shares issued	(0.2)	–	–	–

	Latest Jun 26	FY 25	FY 24
Other intangibles	0.3	0.4	2.6
Property, plant & equipment	0.8	1.1	2.5
Inventories	1.1	1.3	1.6
Trade receivables	2.2	1.7	2.1
Cash	2.9	7.3	10.4
Current assets	6.2	10.4	–
Total assets	7.8	12.6	25.5
Trade payables	1.4	2.3	2.2
Lease liabilities, current	0.4	0.8	0.9
Current liabilities	2.4	3.8	3.3
Lease liabilities, non-current	0.9	1.0	3.3
Total liabilities	3.7	5.4	7.0
Total equity	4.1	7.2	18.4

	H1 26	H2 25	H1 25	H2 24
Other intangibles	0.3	0.4	2.6	2.6
Property, plant & equipment	0.8	1.1	2.1	2.5
Inventories	1.1	1.3	1.6	1.6
Trade receivables	2.2	1.7	1.7	2.1
Cash	2.9	7.3	5.3	10.4
Current assets	6.2	10.4	9.9	–
Total assets	7.8	12.6	18.1	25.5
Trade payables	1.4	2.3	2.2	2.2
Lease liabilities, current	0.4	0.8	0.9	0.9
Current liabilities	2.4	3.8	3.1	3.3
Lease liabilities, non-current	0.9	1.0	2.8	3.3
Total liabilities	3.7	5.4	6.4	7.0
Total equity	4.1	7.2	11.7	18.4

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.